Evidence map›Paper›PMID 33344687›Full record

ArticleEnvironmental technology & innovation2021

Recent case studies on the use of ozone to combat coronavirus: Problems and perspectives.

Soumya Nagashri Manjunath, M Sakar, Manmohan Katapadi, R Geetha Balakrishna

Abstract read
In one paragraph

Article in Environmental technology & innovation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Observational
  2. Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Ozone application in different industries: A review of recent developments.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2023
    Review
  10. Review
  11. Article
  12. Ozone Eliminates SARS-CoV-2 from Difficult-to-Clean Office Supplies and Clinical Equipment.International journal of environmental research and public health · 2022
    Article
  13. Microbial Inactivation: Gaseous or Aqueous Ozonation?Industrial & engineering chemistry research · 2022
    Article
  14. Review
  15. Inactivation of SARS-CoV-2 by Ozonated Glycerol.Food and environmental virology · 2021
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Soumya Nagashri ManjunathOhio Heart Group, 800 East Broad Street, Columbus, OH 43205, USA.
M SakarCentre for Nano and Material Sciences, Jain University, Bangalore 562112, Karnataka, India.
Manmohan KatapadiOhio Heart Group, 800 East Broad Street, Columbus, OH 43205, USA.
R Geetha BalakrishnaCentre for Nano and Material Sciences, Jain University, Bangalore 562112, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus pandemic has created havoc in the world. COVID-19 is now officially labeled as Severe Acute Respiratory Syndrome-related Coronavirus-SARS-CoV-2. Therefore, it is equally important to combat the virus both inside the human body as well as in the environment. These viruses, being RNA viruses, are found to be susceptible to ozone. Ozone being an unstable molecule can breakup into its split products namely reactive oxygen species and ozonides creating a toxic environment for these viruses. Ozone mainly prevents the membrane fusion with the host cell, thus interfering with their replication. With vast applications of the gas, it has created a new spark in the field of medicine in combating these viruses and many other organisms. In this context, this article provides insights from recent clinical and research studies on the problems and possibilities in employing the ozone to combat the coronaviruses.

Indexed as

Anti-viral therapeuticsCoronavirusCOVID-19Ozone therapySARS-coV-2

Identifiers

PMID33344687
PMCPMC7733684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.